GSK

Q2 results 2015

29 Jul 2015

Commenting on GSK's results, the first since the Novartis transaction closed, CFO Simon Dingemans says sales rose during the period and that newly acquired businesses are performing in line with expectations. He reiterates the company's commitment to sustainable innovation.